Showing results (521-530 of 541) with videos related to
Sort By:
Pageof 55
Clinical & Translational Immunology|February 25, 2021
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variantCheryl Yi-Pin Lee, Siti Naqiah Amrun, Rhonda Sin-Ling Chee, et al.Scientific Reports|November 7, 2023
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta waveYun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.Journal of Clinical Immunology|October 30, 2021
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant InfectionSiew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, et al.Frontiers in Immunology|July 19, 2023
Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBBZi Wei Chang, Yun Shan Goh, Angeline Rouers, et al.Frontiers in Immunology|December 1, 2022
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individualsYun Shan Goh, Angeline Rouers, Siew-Wai Fong, et al.The Journal of Infectious Diseases|November 23, 2023
Variant-Specific IgA Protects Against Omicron InfectionYun Shan Goh, Siew-Wai Fong, Pei Xiang Hor, et al.Lancet (London, England)|August 22, 2020
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort studyBarnaby E Young, Siew-Wai Fong, Yi-Hao Chan, et al.Journal of Medicinal Chemistry|April 24, 2018
Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis LeukemiaHaiyan Yang, Lohitha Rao Chennamaneni, Melvyn Wai Tuck Ho, et al.ACS Medicinal Chemistry Letters|August 16, 2019
Correction to "Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3"Chuhui Huang, Si Si Liew, Grace R Lin, et al.Vaccine|September 6, 2024
Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trialXuan Ying Poh, Anthony Torres-Ruesta, Terence Yoong, et al.Pageof 55